The challenge of managing patients with light-chain cardiac amyloidosis: the value of cardiac magnetic resonance as a guide to the treatment response.
Eur Heart J. 2022;43(45):4736-4738.
MeSH terms: Amyloidosis; Heart; Humans; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy
DOI: 10.1093/eurheartj/ehac526